Gwen A Melincoff Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gwen A Melincoff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gwen A Melincoff. Gwen A Melincoff is Director in Protalix BioTherapeutics, Inc. ($PLX) and Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and Director in Tobira Therapeutics, Inc. ($TBRA) and Director in SOLENO THERAPEUTICS INC ($SLNO).
Latest Insider Trading Transactions of Gwen A Melincoff
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, COLL, PLX, SLNO, TBRA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Option Exercise | A | 2.24 | 40,000 | 89,600 | 81,887 | |
| May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
| May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Grant | A | 0.00 | 4,047 | 0 | 11,007 | 7 K to 11 K (+58.15 %) |
| May 20 2020 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Option Exercise | A | 3.41 | 9,530 | 32,497 | 9,530 | |
| Jan 22 2020 | PLX | Protalix BioTherap ... | Melincoff Gwen A | Director | Option Exercise | A | 3.55 | 40,000 | 142,000 | 40,000 | |
| Nov 20 2019 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Buy | P | 1.54 | 10,000 | 15,364 | 10,000 | 0 to 10 K |
| Jun 12 2019 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Option Exercise | A | 2.50 | 13,000 | 32,500 | 13,000 | |
| Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
| Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Grant | A | 0.00 | 4,707 | 0 | 6,960 | 2.3 K to 7 K (+208.92 %) |
| Apr 29 2019 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Option Exercise | A | 1.98 | 20,000 | 39,600 | 20,000 | |
| May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
| May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Grant | A | 0.00 | 2,253 | 0 | 2,253 | 0 to 2.3 K |
| Aug 11 2017 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 9.89 | 25,067 | 247,913 | 25,067 | |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
| Nov 03 2016 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | D | 8.13 | 13,539 | 110,072 | 0 | |
| Jan 14 2016 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
| Jul 13 2015 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Melincoff Gwen A | Director | Option Exercise | A | 8.13 | 13,539 | 110,072 | 13,539 |
Page: 1